9/12/2004 Change of Director's Interest Notice 29/12/2004 Change in substantial holding 29/12/2004 Change of Director's Interest Notice 29/12/2004 Appendix 3B - Share & Option Issue
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling